TIDES: Oligonucleotides and Peptide Therapeutics’ Post

The latest EarthRate ESG Pharma and Biotech weekly (5.4.2024): - new Covid - cases at low levels in Europe - Q1 2024 Covid deaths in the US over 23.000 - Novo Nordisk and Nvidia to build AI supercomputer in Denmark - new healthcare listing in the US : Solventum in Nyse - most pharma stocks declined during the week's period Read the report here: www.pubplus.club #earthrate,#esginvesting #pharma #biotech

Not only does Sweden have a thriving economy that largely depends on manufacturing and exports, but it also has a thriving life sciences sector. 🌟 In fact, did you know that, in 2020, the country’s life sciences sector recorded a net turnover of almost SEK 365 billion ($34 billion)? 💰 This marks an impressive increase of just over SEK 158 billion ($14.8 billion) since 2014. 📈 Read our latest article, as we take a look at eight Swedish companies spearheading the growth of the country’s biotech scene! 🔬🇸🇪 https://lnkd.in/dkMQYQUw #swedishbiotech #lifesciences #biotech #innovation #healthcare #economicgrowth #biotechindustry #manufacturing #biotechnews #pharma #biotechcompanies  #swedisheconomy Amferia | Anocca | Aprea Therapeutics | Asgard Therapeutics | BioInvent International AB | Diamyd Medical | Hamlet BioPharma | Modus Therapeutics Holding AB

11 Biopharma Trends to Watch in 2024

📢 Attention, time change! May 16th, at 14:40, Stage 5    ✅ "From risk to remedy – Polish biotech's answers to sustain stable drug and diagnostics supply during shortages"  🎤 Join the discussion panel at Impact CEE, where Konstantin Matentzoglu (Polpharma Biologics) alongside Katarzyna Rolle (Polish Academy of Sciences), Dariusz Adamusiński (MedTech Poland), and moderator Joanna Bekker (Polityka Insight) will discuss how collaboration between businesses and science can strengthen supply chains when needed. Don't miss this important discussion! #IMPACTCEE #Innovation #Biotechnology #PolpharmaBiologics

Check out our recently published article "Unlocking Success: How Reference Standards Empower Small Biotech Companies" in BioPharma Insights (BioPharm International)! This article is an excellent resource if you are running a small or mid-sized biotechnology company and are seeking ways to enhance your operations, shorten developmental timelines, and achieve success in the market. USP reference standards can be indispensable tools for mitigating some of the risks that can prevent you from achieving your goals. Our products can provide a critical foundation for small and mid-sized companies navigating their complex drug development and manufacturing journey. To learn more, go to https://ow.ly/KVNg50QpnK6 #innovation #biotechnology #USPScience #standards #mabs

We are thrilled to announce that we have been awarded a grant by Innovate UK via the Future Economy Investor Partnerships SME program. The objective of the grant is to scale-up manufacturing capability for allogeneic cell therapies. There is a huge pipeline of therapies predicted to enter the market in the next decade but the industry is lacking the vital tools and technologies to meet forecast demand. As experts in continuous processing of adherent cells, this grant will permit the development of a scalable, cost effective, and reproducible method of expanding hiPSCs for use in therapy development and manufacturing. A huge thanks to Innovate UK and Northstar Ventures UK for their support. #cellmanufacturing #celltherapy #biomanufacturing #cellculture #bioprocessing #processautomation #biosciences #biotechnology #biopharma #pharma #biotech #innovation #biotechnology #bioengineering #celltherapies #ukrinews # innovateuk

In 2001, we came up with the concept of High Throughput Development and what strategies could be implemented. HTD Biosystems was founded to address the challenge of how could one develops more drugs with less material, limited resources, fast timelines, and reduced cost. Now, it is gratifying to see that with the development of high throughput instruments and the systems we refined at HTD, this wass possible. We have had many successes in helping emerging biotech companies develop their "Babies" into adult Drug Products and into the clinic or Big Pharma over the past 23 years and we are not done yet. Looking forward to working with the next generation of biotech companies and new modalities. #drug development, #biotechnology, #HTD biosystems,

🌟 Join Our Exclusive Manufacturing Roundtable Sessions (Track 3), Oligonucleotide Therapeutics Xchange, Boston. 🌟 Register for free: https://bit.ly/3wYHLnQ Are you passionate about the latest advancements in manufacturing and eager to stay ahead of the curve in the biotech industry? Don't miss out on our upcoming roundtable sessions, expertly tailored for you! 📅 Date: June 21, 2024 ⏰ Time: 08:00 - 17:40 📍 Location: Woburn Hilton Hotel, 2 Forbes Road, Woburn, MA, 01801, US ⭐ Here's the highlights: 📑 Downstream manufacturing challenges for synthetic oligonucleotides. 🗣️ Firoz Antia, Executive Director, Head of Oligonucleotide Development, Biogen 📑 Current challenges for drug substance CDMOs in the Oligonucleotide space. 🗣️ Trishul Shah, Director Business Development, Head of Sales North America, PolyPeptide Group 📑 Novel methodologies to manufacture Oligonucleotides. 🗣️ Mayur Patel, PhD, Director, Oligonucleotides Chemistry, Korro Bio, Inc. Our Partners 🔺 ChemGenes 🔺 PolyPeptide Group 🔺 Nitto Avecia 🔺 WuXi Biologics 🔺 Nostrum Biodiscovery 🔺 Vazyme Biotech * Agenda subject to change. 💊 Only available for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. 💊 #Manufacturing #Biotech #Oligonucleotides #Networking #ProfessionalDevelopment #Pharma #Biotechnology #Chemistry #Science #Innovation #Roundtable #Roundtables #NetworkingEvent #IndustryLeaders #BusinessDevelopment #CareerGrowth #LearningOpportunity #NetworkingRoundtables #Research #Technology #Collaboration #Leadership #Expertise #Insights #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimenatryPass

this survey allows biotechs to show pharma companies what really matters to them when it comes to partnering

Wondering why so many of #Nextflow users are working with Seqera? Here are five of the top reasons 😎